Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Antipsychotics
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Antipsychotics'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Antipsychotics
100%
Pharmacokinetic Model
25%
Pharmacodynamic Model
25%
Tolerability
12%
Adverse Events
12%
Clinical Response
12%
Psychiatric Disease
12%
Clinical Practice
12%
Plasma Concentration
12%
Pharmacodynamic Interactions
12%
Pharmacodynamics
12%
Therapeutic Effect
12%
Receptor Binding
12%
Daily Dose
12%
P-glycoprotein (P-gp)
12%
Patients with Schizophrenia
12%
Schizophrenia
12%
Bipolar Disorder
12%
Dopamine Receptor
12%
Prolactin
12%
Sedation
12%
Therapeutic Plasma
12%
Everyday Practices
12%
Lurasidone
12%
Ziprasidone
12%
Psychotic
12%
Therapeutic Range
12%
Population Pharmacokinetic Analysis
12%
Chronic Disease Management
12%
Cardiovascular Action
12%
Inhalation
12%
Schizoaffective
12%
CYP Enzymes
12%
Paliperidone
12%
Event Characteristics
12%
Sublingual
12%
Long-acting Depot
12%
Antipsychotic Dose
12%
Change Actions
12%
QT Prolongation
12%
Asenapine
12%
Iloperidone
12%
Depot Antipsychotic
12%
Pharmacology, Toxicology and Pharmaceutical Science
Typical Antipsychotic
100%
Pharmacodynamics
57%
Antipsychotic
42%
Pharmacokinetics
42%
Receptor
14%
Tolerability
14%
Adverse Event
14%
P-Glycoprotein
14%
Receptor Subtype
14%
Bipolar Disorder
14%
Therapeutic Effect
14%
Dopamine Receptor
14%
Prolactin
14%
Lurasidone
14%
Ziprasidone
14%
Cholinergic Receptor Blocking Agent
14%
Chronic Disease
14%
Paliperidone
14%
Asenapine
14%
Iloperidone
14%
Polyethylene Terephthalate
14%